Skip to main content

User account menu

  • Log in
X

Main navigation

  • Resources
    • News
    • Expert Insights
    • Interactive Features
    • Podcasts
    • Videos
  • Specialties
    • Colorectal Cancer
    • Colorectal Diseases and Disorders
    • Crohn Disease
    • Disorders of gut-brain interaction
    • Esophageal Diseases and Disorders
    • Hepatic Diseases and Disorders
    • Infection
    • Inflammatory Bowel Disease
    • Irritable Bowel Syndrome
    • Nutrition
    • Pancreatic Diseases and Disorders
    • Patients and Practice
    • Pediatric Gastroenterology
    • Procedures and Therapeutics
    • Stomach and Small Bowel Diseases and Disorders
    • Ulcerative Colitis
  • Excellence Forums
    • Colorectal Cancer
    • Colorectal Diseases and Disorders
    • Crohn Disease
    • Esophageal Diseases and Disorders
    • Gastroesophageal Reflux Disease
    • Hepatic Diseases and Disorders
    • Inflammatory Bowel Disease
    • Irritable Bowel Syndrome
    • NALFD/NASH
    • Nutrition
    • Pancreatic Diseases and Disorders
    • Patients and Practice
    • Pediatric Gastroenterology
    • Procedures and Therapeutics
    • Stomach and Small Bowel Diseases and Disorders
    • Ulcerative Colitis
  • Meetings
    • Advances in Inflammatory Bowel Disease 2021 Regionals
    • Advances in Inflammatory Bowel Disease
    • American Association for the Study of Liver Diseases
    • American College of Gastroenterology Clinical Meeting
    • Crohn's & Colitis Congress 2021
    • Harvard Nonalcoholic Fatty Liver Disease Symposium
    • Interdisciplinary Autoimmune Summit
    • North American Society For Pediatric Gastroenterology, Hepatology & Nutrition
  • CME
    • Program Listing
  • About
    • Contact Us
    • Editorial Description
    • Section Editors
  • Search
Search Search
Featured
Miguel Regueiro, MD, on Considerations for the “New Kid” on the Block: S1P Modulators
Dr Regueiro, professor and chair of the Department of Gastroenterology, Hepatology, and Nutrition at the Cleveland Clinic, spoke to the Advances in Inflammatory Disease regional meeting on April 16 about the potential and promise of a new therapeutic agent, S1P modulators.
Michael Chiorean, MD, on Stopping or De-escalating IBD Therapy
Christina Ha, MD, on Managing IBD Care for the Young Adult
Michael Chiorean, MD, on the Optimal Use of JAK Inhibitors in IBD
Gil Y. Melmed, MD, on Strategies for Treating C. difficile in IBD
Gil Y. Melmed, MD, on Positioning Therapies in IBD
Alan Bonder, MD, and Daniela Goyes, MD, on Diagnosing and Managing Autoimmune Hepatitis
Brian Lacy, MD, and Benjamin Lebwohl, MD, on Celiac Disease
Sara Horst, MD, and David Schwartz, MD, on Managing Patient Expectations in Treating Crohn Disease

News

Researchers Reveal Model-Based Estimation of CRC Screening and Outcomes During Pandemic
Imaging System Distinguishes Residual Rectal Cancer from Treatment Scarring
1-Food Elimination Tested Among Pediatric Patients With EoE
Links Found Between Genetic Micronutrients and Risk of Colorectal Cancer
SARS-CoV-2 Significantly Worsens Outcomes in Patients With Acute Pancreatitis
Aspirin, SSRIs Associated with Reduced Risk of Colorectal Cancer
View More

Excellence Forums

Esophageal Diseases and Disorders
Inflammatory Bowel Disease
NALFD/NASH
Ulcerative Colitis

Newsrooms

Advances in Inflammatory Bowel Disease 2021 Regionals
American Association for the Study of Liver Diseases
American College of Gastroenterology Clinical Meeting
Crohn's & Colitis Congress 2021

Continuing Education

Pursuing a Gut Feeling: Exploring Immune Cell Trafficking Inhibitors to Treat IBD
COVID-19 & Solid Tumors: Module 2 – Lung Tumors Update 1
COVID-19 & Solid Tumors: Module 3 – Lung Tumors Update 2
COVID-19 & Solid Tumors: Module 4 – GI Tumors Expert Roundtable
COVID-19 & Solid Tumors: Module 5 – GI Tumors Update 1
Stay in the know.
NLN Newsletter

CONNECT

  • Facebook
  • Twitter
  • Linkedin

ABOUT

Footer

  • About Us
  • Contact Us
  • Privacy Policy

VISIT OUR OTHER BRANDS

Footer Brands

  • AIBD Regionals
  • Advances in Inflammatory Bowel Diseases (AIBD) Conference
  • Autoimmune Learning Network
© 2021 HMP. Rx Summit is a trademark of HMP. All Rights Reserved.